Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Migraine Headaches: early-phase trial registry

1 of 5 indexed Migraine Headaches trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Migraine Headaches: 5 US clinical trials tracked, 1 recruiting.

Migraine Headaches is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Memorial Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition migraine-headaches

OPEN 1 | RECR 20% | LATE 1 | EARLY 3 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Migraine Headaches (this)20%
Open-enrollment share among volume-matched conditions near Migraine Headaches

Migraine Headaches lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Migraine Headaches on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Migraine Headaches is recruiting below its size-band peers.

    1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Migraine Headaches research.

    Memorial Medical Center accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Migraine Headaches trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Migraine Headaches research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Migraine Headaches records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

acupuncture Procedure
1 trials
ELS-M11 Drug
1 trials
RWJ-333369 Drug
1 trials
Zavegepant Drug
1 trials
Rimegepant Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Migraine Headaches trials. A trial with sites in several states counts in each.

Texas 2 trials
Tennessee 1 trials
South Carolina 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials
North Dakota 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Migraine Headaches page

5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Migraine Headaches condition card totals 5 registered trials; most-linked intervention acupuncture; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.